BB Biotech at high loss in the first quarter – share in red | 04/24/20
The holding company BB Biotech posted a high loss in the first quarter of 2020 due to the price declines on the stock exchanges. The period presented an extraordinary challenge for investors, the company wrote in a message on Friday. For the first three months, BB Biotech posted a net loss of CHF 758 million … Read more